Phase 1 study of twice-weekly ixazomib, an oral proteasome inhibitor, in relapsed/refractory multiple myeloma patients (Q33415893)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase 1 study of twice-weekly ixazomib, an oral proteasome inhibitor, in relapsed/refractory multiple myeloma patients |
scientific article |
Statements
1 reference
Phase 1 study of twice-weekly ixazomib, an oral proteasome inhibitor, in relapsed/refractory multiple myeloma patients (English)
1 reference
Sagar Lonial
1 reference
Paul G Richardson
1 reference
Andrzej J Jakubowiak
1 reference
Rachid Baz
1 reference
Michael Wang
1 reference
Jacob P Laubach
1 reference
R Donald Harvey
1 reference
Moshe Talpaz
1 reference
Deborah Berg
1 reference
Guohui Liu
1 reference
Jiang Yu
1 reference
Neeraj Gupta
1 reference
Alessandra Di Bacco
1 reference
Ai-Min Hui
1 reference
11 June 2014
1 reference
1 reference
124
1 reference
1038-1046
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference